Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q59199518
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000234.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q59199518
|
024
|
|
|
‡a
0000-0003-2236-1029
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q59199518
|
100
|
0 |
|
‡a
Joana Barbosa
‡c
researcher ORCID ID = 0000-0003-2236-1029
‡9
en
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Joana Barbosa
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Acute administration of tramadol and tapentadol at effective analgesic and maximum tolerated doses causes hepato- and nephrotoxic effects in Wistar rats.
|
670
|
|
|
‡a
Author's Clinicopathologic significance of BubR1 and Mad2 overexpression in oral cancer.
|
670
|
|
|
‡a
Author's Comparative metabolism of tramadol and tapentadol: a toxicological perspective.
|
670
|
|
|
‡a
Author's Comparative pharmacology and toxicology of tramadol and tapentadol.
|
670
|
|
|
‡a
Author's Comparative study of the neurotoxicological effects of tramadol and tapentadol in SH-SY5Y cells
|
670
|
|
|
‡a
Author's Effective analgesic doses of tramadol or tapentadol induce brain, lung and heart toxicity in Wistar rats.
|
670
|
|
|
‡a
Author's Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint
|
670
|
|
|
‡a
Author's Repeated Administration of Clinical Doses of Tramadol and Tapentadol Causes Hepato- and Nephrotoxic Effects in Wistar Rats
|
909
|
|
|
‡a
(orcid) 0000000322361029
‡9
1
|
919
|
|
|
‡a
effectiveanalgesicdosesoftramadolortapentadolinducebrainlungandhearttoxicityinwistarrats
‡A
Effective analgesic doses of tramadol or tapentadol induce brain, lung and heart toxicity in Wistar rats.
‡9
1
|
919
|
|
|
‡a
comparativestudyoftheneurotoxicologicaleffectsoftramadolandtapentadolinshsy5ycells
‡A
Comparative study of the neurotoxicological effects of tramadol and tapentadol in SH-SY5Y cells
‡9
1
|
919
|
|
|
‡a
repeatedadministrationofclinicaldosesoftramadolandtapentadolcauseshepatoandnephrotoxiceffectsinwistarrats
‡A
Repeated Administration of Clinical Doses of Tramadol and Tapentadol Causes Hepato- and Nephrotoxic Effects in Wistar Rats
‡9
1
|
919
|
|
|
‡a
comparativepharmacologyandtoxicologyoftramadolandtapentadol
‡A
Comparative pharmacology and toxicology of tramadol and tapentadol.
‡9
1
|
919
|
|
|
‡a
acuteadministrationoftramadolandtapentadolateffectiveanalgesicandmaximumtolerateddosescauseshepatoandnephrotoxiceffectsinwistarrats
‡A
Acute administration of tramadol and tapentadol at effective analgesic and maximum tolerated doses causes hepato- and nephrotoxic effects in Wistar rats.
‡9
1
|
919
|
|
|
‡a
monitoringthefidelityofmitoticchromosomesegregationbythespindleassemblycheckpoint
‡A
Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint
‡9
1
|
919
|
|
|
‡a
comparativemetabolismoftramadolandtapentadolatoxicologicalperspective
‡A
Comparative metabolism of tramadol and tapentadol: a toxicological perspective.
‡9
1
|
919
|
|
|
‡a
clinicopathologicsignificanceofbubr1andmad2overexpressioninoralcancer
‡A
Clinicopathologic significance of BubR1 and Mad2 overexpression in oral cancer.
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
PTBNP|1624918
|
996
|
|
|
‡2
ISNI|0000000109648426
|
996
|
|
|
‡2
ISNI|0000000068284979
|
996
|
|
|
‡2
PTBNP|1574889
|
996
|
|
|
‡2
SUDOC|128564377
|
996
|
|
|
‡2
PTBNP|1793197
|
996
|
|
|
‡2
PTBNP|1888122
|
996
|
|
|
‡2
PTBNP|1532763
|
996
|
|
|
‡2
PTBNP|1809989
|
996
|
|
|
‡2
PTBNP|229121
|
996
|
|
|
‡2
DNB|1145579302
|
996
|
|
|
‡2
NUKAT|n 2007137587
|
996
|
|
|
‡2
PTBNP|1615756
|
996
|
|
|
‡2
ISNI|0000000070720880
|
996
|
|
|
‡2
PTBNP|1243407
|
996
|
|
|
‡2
BNCHL|10000000000000000147989
|
996
|
|
|
‡2
BLBNB|001583778
|
996
|
|
|
‡2
NII|DA00665852
|
996
|
|
|
‡2
RERO|A002968384
|
996
|
|
|
‡2
PTBNP|1708156
|
996
|
|
|
‡2
SUDOC|265418275
|
996
|
|
|
‡2
SUDOC|221651284
|
996
|
|
|
‡2
BIBSYS|90238915
|
996
|
|
|
‡2
SUDOC|112147240
|
996
|
|
|
‡2
PTBNP|1590408
|
996
|
|
|
‡2
BLBNB|000326924
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|